BfArM
- Local brand name: Tepmetko
- Status: approved
TEPOTINIB (TEPOTINIB) regulatory status in Germany.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. BfArM has authorised it.
Marketing authorisation holder not available in our data.